A race for RAGE ligands.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 20631734.
- Also identified by DOI 10.1038/ki.2010.146.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In experimental animals a causal involvement of the multiligand receptor for advanced glycation end products (RAGE) in the development of diabetic vascular complications has been demonstrated. However, the nature of RAGE ligands present in patients with diabetic nephropathy has not yet been defined; this leaves open the relevance of the RAGE system to the human disease.
Medical subject headings
- Diabetic Nephropathies
- Receptors, Immunologic